What is the Royal College of Obstetricians and Gynaecologists (RCOG) definition of recurrent pregnancy loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

RCOG Definition of Recurrent Pregnancy Loss

The Royal College of Obstetricians and Gynaecologists (RCOG) defines recurrent pregnancy loss as the loss of three or more consecutive pregnancies before 24 weeks of gestation. 1

Key Diagnostic Criteria

The RCOG definition requires specific elements to establish the diagnosis:

  • Three or more consecutive pregnancy losses occurring before 24 weeks of gestation 1
  • Clinically recognized pregnancies only (confirmed by ultrasound or hCG testing) 1
  • Anembryonic pregnancies (blighted ova) are included in the count, as they represent confirmed early pregnancy losses that meet diagnostic criteria 1, 2

Important Clinical Context

Comparison with Other International Guidelines

The RCOG definition differs from other major international societies, creating some clinical confusion:

  • RCOG requires three consecutive losses before initiating formal evaluation 1, 3
  • The American Society for Reproductive Medicine (ASRM) and European Society of Human Reproduction and Embryology (ESHRE) define recurrent pregnancy loss as two or more losses, representing a lower threshold for investigation 3, 4
  • This definitional inconsistency affects the reported incidence, which ranges from 1% to 5% depending on which criteria are applied 5

Clinical Implications of the Three-Loss Threshold

The RCOG's requirement for three losses before formal evaluation may delay diagnosis and treatment for some couples. 4 Research demonstrates that nulliparous women with two consecutive first-trimester miscarriages who receive supportive care achieve excellent outcomes, with 72.7% achieving live birth in subsequent pregnancies 4. This evidence suggests that earlier intervention after two losses may be beneficial, particularly for women without living children.

What Counts as a Loss

The RCOG definition specifically includes:

  • Anembryonic pregnancies (gestational sac ≥25 mm without an embryo, or absence of embryo on serial examinations) 2
  • These must be intrauterine pregnancies confirmed by ultrasound or hCG 1
  • The pregnancy must be clinically recognized, not biochemical pregnancies alone 2

Common Pitfall

Do not exclude anembryonic pregnancies from your count when determining if a patient meets RCOG criteria for recurrent pregnancy loss. These represent confirmed conceptions with failed development and are explicitly included in the definition 1, 2. Anembryonic pregnancies frequently result from chromosomal errors (50-60% of early losses), the same mechanism as other early pregnancy losses 2.

References

Guideline

Recurrent Pregnancy Loss Definition and Diagnostic Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Recurrent Pregnancy Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A review of reproductive outcomes of women with two consecutive miscarriages and no living child.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019

Related Questions

What is the Royal College of Obstetricians and Gynaecologists (RCOG) definition of recurrent pregnancy loss in women of childbearing age?
What is the best management approach for a pregnant woman with a history of 3 recurrent pregnancy losses, including 1 blighted ovum and 1 pregnancy with abnormal umbilical Doppler findings, who also has positive antibodies against a non-specific antigen?
What is the likely cause of recurrent early miscarriages in a patient with a history of three previous early pregnancy losses, now presenting with a non-viable pregnancy at 6 weeks?
What is the best predictor of pregnancy complications in a patient with a history of recurrent pregnancy loss?
What dose of estrogen should be prescribed for a 3-week period to build the endometrium in a 31-year-old woman with a history of recurrent pregnancy loss and stage 4 endometriosis, who has undergone excision surgery and is being treated with Lupron (leuprolide) and letrozole (an aromatase inhibitor) 5mg for 90 days, and has 8 PGT (preimplantation genetic testing)-tested normal embryos?
What is the best management approach for an elderly male patient with complex rotator cuff pathology, including full-thickness tears of the supraspinatus, infraspinatus, and long head of biceps tendon, adhesive capsulitis, acromioclavicular osteoarthrosis, and a history of asbestos exposure?
What is the Royal College of Obstetricians and Gynaecologists (RCOG) definition of recurrent pregnancy loss in women of childbearing age?
What are the dosing considerations for Pregablin (Lyrica) in patients with impaired renal function, epilepsy, neuropathic pain, or fibromyalgia?
What are alternative lipid-lowering therapies for a patient with high cholesterol who is allergic to statins (HMG-CoA reductase inhibitors)?
How can a woman with polycystic ovary syndrome (PCOS), normal body mass index (BMI), and dyslipidemia determine if she has estrogen dominance?
What is the treatment indication for a patient with a confirmed diagnosis of hepatitis C virus (HCV)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.